Related by context. All words. (Click for frequent words.) 74 efficacy 71 analgesic efficacy 71 pharmacodynamics PD 70 tolerability 70 pharmacodynamic properties 69 urate lowering 69 NP2 Enkephalin 69 Dabigatran etexilate 69 AZILECT R 69 tanespimycin 69 optimal dosing 69 pharmacokinetic profiles 69 tolerability profiles 69 teriflunomide 68 riociguat 68 LibiGel ® 68 pharmacokinetics pharmacodynamics 68 pharmacodynamic markers 68 clevidipine 68 favorable pharmacokinetic profile 67 Hyphanox 67 tolerability pharmacokinetics 67 orally inhaled migraine 67 Perforomist ™ Inhalation Solution 67 REMINYL ® 67 vidofludimus 67 Archexin 67 Dual Opioid 67 pharmacokinetics PK 67 MAGE A3 ASCI 67 Zoraxel 67 MoxDuo IR 67 limiting toxicity DLT 67 Octreolin 67 pharmacodynamic profile 67 MoxDuo 67 Panzem R 67 galiximab 67 Azedra 67 pregabalin Lyrica 67 CorVue ™ 67 oral rivaroxaban 67 TNF alpha inhibitor 67 antidiabetic drugs 67 CIMZIA ™ 66 EXPAREL ™ 66 maximally tolerated dose 66 thetreatment 66 favorable tolerability 66 LEP ETU 66 MGN# 66 AZILECT ® 66 tolerability profile 66 bicifadine 66 Onbrez Breezhaler 66 SPIRIVA HandiHaler 66 oral prodrug 66 pertuzumab 66 KRN# 66 dual antiplatelet 66 trospium 66 Q#IR 66 torezolid phosphate 66 Zemplar Capsules 66 ADAGIO study 66 RE SURGE 66 LEVADEX ™ 66 Zenvia ™ 66 rNAPc2 66 NATRECOR ® 66 Raptiva ® 66 CINQUIL 66 tipranavir 66 Alequel ™ 66 systemic immunosuppressive drugs 66 pharmacokinetic PK 66 lapatinib Tykerb 66 Afatinib 66 CIMZIA TM certolizumab pegol 66 fosbretabulin 66 UPLYSO 66 Combo Stent 66 non selective NSAIDs 65 pharmacokinetic equivalence 65 antiepileptics 65 HuMax EGFr 65 inhaled iloprost 65 preclinical efficacy 65 liposomal formulation 65 DexaSite 65 zonisamide SR 65 CRMD# 65 ruxolitinib 65 Exelixis compounds 65 constipation OIC 65 neratinib 65 tezampanel 65 Tekturna HCT 65 novel VDA molecule 65 novel oral anticoagulant 65 Empatic 65 pharmacokinetic parameters 65 RoACTEMRA 65 dosage regimens 65 Tasimelteon 65 cannabinor 65 active comparator 65 Golimumab 65 safety tolerability pharmacokinetic 65 pioglitazone HCl 65 octreotide acetate 65 visilizumab 65 ACIPHEX 65 investigational humanized monoclonal antibody 65 ATACAND 65 NeuroSTAT ® 65 HCV protease inhibitors 65 Dalbavancin 65 Vidaza azacitidine 65 ganaxolone 65 pain palliation 65 CANCIDAS 65 Linjeta TM 65 HIF PH inhibitors 65 sorafenib tablets 65 JAK inhibitor 65 Zenvia Phase III 65 reactogenicity 65 BAL# [002] 65 SUTENT ® 65 alvespimycin 65 angiotensin receptor blocker ARB 65 severe gastroparesis 65 casopitant 65 elotuzumab 65 antithrombotic 65 FOLOTYN ® 65 either acutely decompensated 65 melphalan prednisone 64 pharmacokinetic profile 64 endothelin antagonist 64 eprotirome 64 Poly ICLC 64 reslizumab 64 ORENCIA ® 64 PREOS 64 antiarrhythmic drug 64 Diovan HCT 64 Eli Lilly Cymbalta 64 HGS# 64 Surfaxin LS 64 alfuzosin 64 Panzem R NCD 64 ZOLINZA 64 MYCAMINE 64 CIMZIA TM 64 oral salmon calcitonin 64 Zoraxel TM 64 Mycophenolate Mofetil 64 nab paclitaxel 64 RE LY ® 64 combinability 64 Alvesco R 64 Carvedilol 64 fenofibric acid 64 Keppra XR 64 pharmacodynamic PD 64 pharmacodynamic parameters 64 Traficet EN 64 Tarceva TM 64 pharmacodynamic effects 64 Oral NKTR 64 GAMMAGARD 64 alvimopan 64 Prospective Randomized 64 Spiriva Handihaler 64 TLK# 64 diabetic neuropathic pain 64 SILENOR 64 ganetespib 64 Cardio Vascu Grow 64 Dyloject TM 64 Targretin 64 intravenous cyclophosphamide 64 zileuton 64 interferon gamma 1b 64 LEVAQUIN ® 64 Rebif ® 64 Androxal TM 64 Ophena TM 64 dosing frequency 64 safety tolerability pharmacokinetics 64 ticagrelor Brilinta 64 Elocalcitol 64 TELINTRA 64 Tolvaptan 64 denileukin diftitox 64 donepezil Aricept 64 INC# 64 Resten NG 64 direct thrombin inhibitors 64 Dapagliflozin 64 Safinamide 64 PEGylated interferon beta 1a 64 Vimpat R 64 topiramate Topamax 64 FOLFOX6 chemotherapy regimen 64 desvenlafaxine 64 TREDAPTIVE 64 AAG geldanamycin analog 64 Inhalation Solution 64 miconazole Lauriad ® 64 Vascugel ® 64 metaglidasen 64 Vilazodone 64 intranasal formulation 64 docetaxel Taxotere ® 64 ACUROX ® 64 Factor VIIa 64 VAPRISOL 64 Cancidas 64 LHRH antagonists 64 ALGRX 64 Sanctura XR 64 candesartan cilexetil 64 Fondaparinux 64 subcutaneous formulation 64 Fidaxomicin 64 potency selectivity 64 Elagolix 64 Cotavance 64 lucinactant 64 multicenter Phase III 64 Methylnaltrexone 64 prucalopride 64 myopathy rhabdomyolysis 63 evaluating tivozanib 63 Pirfenidone 63 Interferon beta 1a 63 CoFactor 63 Tekamlo 63 deferiprone 63 glatiramer acetate 63 PRT# 63 selective modulator 63 antiplatelet agent 63 tasimelteon 63 Firazyr 63 mg kg BID 63 pharmacokinetic characteristics 63 Foradil Aerolizer 63 ® pioglitazone HCl 63 IMiDs 63 BRAF inhibitor 63 Cimzia TM 63 cystinosis patients 63 intravenous acetaminophen 63 Vascular Wrap TM 63 mu opioid receptor antagonist 63 safinamide 63 topical calcineurin inhibitors 63 vildagliptin 63 ACTEMRA TM 63 Ambrisentan 63 Eluting Coronary Stent System 63 BrachySil TM 63 Ampakine 63 Increlex ® 63 investigational therapies 63 TriRima 63 AVANDIA 63 AEGR 63 #D#C# 63 Tolerability 63 adipiplon 63 serotonin norepinephrine reuptake inhibitor 63 Targretin capsules 63 Anturol TM 63 NEVO TM 63 Ereska 63 rhIGF-I/rhIGFBP-3 63 TBC# 63 erythropoietic 63 ULORIC 63 antiviral efficacy 63 placebo controlled studies 63 Bicifadine 63 TASKi3 63 PI3K/Akt pathway inhibitor 63 SERMs 63 vapreotide acetate 63 anti emetic therapy 63 Ramelteon 63 OMNARIS HFA 63 antidepressant efficacy 63 TOLAMBA 63 preclinically 63 CaPre TM 63 Protelos 63 Pemetrexed 63 alemtuzumab MS 63 ARIKACE ™ 63 Muraglitazar 63 Enhanze Technology 63 SARMs 63 aripiprazole Abilify 63 Triapine R 63 Aurexis 63 oral renin inhibitor 63 Icatibant 63 AZILECT 63 Entereg R 63 PSN# [002] 63 Dual Opioid TM 63 APTIVUS 63 eluting stent 63 glycopyrrolate 63 Androxal ® 63 KAPIDEX 63 dosing regimens 63 HMG CoA reductase inhibitors 63 USL# 63 Focalin XR 63 Phase 1b trial 63 Efficacy Results 63 R#/MEM 63 Ketotransdel 63 INVEGA ® 63 renal toxicity 63 ARCOXIA 63 Zelrix 63 Noxafil 63 noninfectious uveitis 63 SCH # 63 liposomal doxorubicin 63 Phase #b/#a 63 PEG SN# 63 EMBEDA ™ 63 Tracleer R 63 pomalidomide 63 anti arrhythmic 63 Plenaxis TM 63 orally administered inhibitor 63 Ticagrelor 63 Pitavastatin 63 ONTARGET 63 Desvenlafaxine 63 bazedoxifene conjugated estrogens 63 LUNESTA brand eszopiclone 63 methylnaltrexone bromide 63 VIAject R 63 DDP# 63 Denufosol 63 LIALDA 63 sargramostim 63 placebo controlled clinical 63 EVIZON 63 STRIDE PD 63 INS# [001] 63 mertansine 63 SinuNase TM 63 Zometa zoledronic acid 63 pharmacodynamic 63 mapatumumab 63 TYSABRI natalizumab 63 receptor tyrosine kinase inhibitor 63 DASISION 63 arzoxifene 63 regorafenib 63 incyclinide 63 NOXAFIL 63 Pertuzumab 63 Exforge HCT 63 Chemophase 63 SYNERGY Stent 63 Tyrima 62 Clonicel 62 phase IIIb 62 Personalized Immunotherapy 62 SIMCOR 62 pharmacoeconomic 62 Phase 2b clinical trials 62 TPI ASM8 62 DACH platinum 62 PKC# 62 Ziprasidone 62 subcutaneous dosing 62 Orazol 62 Augment Injectable 62 oral ridaforolimus 62 TH# [003] 62 velafermin 62 Oxybutynin 62 nicardipine 62 capsule formulation 62 antiangiogenic agents 62 forodesine 62 rHuPH# 62 6R BH4 62 Pimavanserin 62 EP #R 62 antiplatelet therapies 62 NasalFent 62 rosuvastatin calcium 62 hylan GF 62 MyVax R 62 Clolar ® 62 Zorbtive TM 62 MoxDuo TM IR 62 CINTREDEKIN BESUDOTOX 62 selective A2A adenosine receptor 62 BRILINTA 62 NexACT ® 62 thalidomide Thalomid 62 oral FTY# 62 TAXUS VI 62 Vernakalant 62 antitumor effect 62 ADVEXIN therapy 62 Quetiapine 62 omeprazole Prilosec 62 Ixempra 62 Initiate Clinical Trial 62 SANVAR 62 oral diclofenac 62 pyridostigmine 62 histone deacetylase inhibitor 62 Phase Ib study 62 perampanel 62 certolizumab 62 INCB# [001] 62 pharmacokinetic properties 62 aplindore 62 ixabepilone 62 clinically meaningful efficacy 62 Femara letrozole 62 varespladib 62 sunitinib malate 62 Bezielle 62 Synavive 62 CYPHER R Sirolimus eluting 62 RELOVAIR ™ 62 YONDELIS 62 antiplatelet 62 Proquin XR 62 antithrombotics 62 clopidogrel Plavix 62 GLYX 62 INFERGEN 62 Warfarin Coumadin 62 Zoloft sertraline 62 CTAP# Capsules 62 IPLEX 62 desvenlafaxine succinate 62 Ventavis ® 62 pramlintide metreleptin combination 62 phase IIb clinical 62 neuroprotective properties 62 Mycamine 62 etanercept Enbrel 62 trodusquemine 62 Alequel 62 Prosaptide 62 Inhaled AAT 62 ASM8 62 Interferon beta 62 ciclesonide 62 lumiliximab 62 ORENCIA R 62 EmbraceAC 62 Virulizin ® 62 PEGylated anti 62 Meets Primary Endpoint 62 Cellegesic 62 Ocrelizumab 62 Valsartan 62 leukotriene receptor antagonist 62 diabetic gastroparesis 62 hematological parameters 62 nebulized formoterol fumarate 62 Spiegelmer ® 62 Vidofludimus 62 Trobalt 62 topically applied SEPA 62 enzastaurin 62 ZYBRESTAT fosbretabulin 62 Onrigin 62 erlotinib Tarceva ® 62 topical NSAIDs 62 peripherally acting 62 IMC A# 62 Aliskiren 62 immunotherapeutic vaccine 62 Catena ® 62 DuraSite ® 62 bronchodilation 62 statin simvastatin 62 epoetin zeta 62 fondaparinux sodium 62 Acute Ischemic Stroke 62 PXD# 62 Amrubicin 62 RE LY 62 tecarfarin 62 Natalizumab 62 LCP AtorFen 62 salmeterol fluticasone 62 MiStent DES 62 Factor Xa inhibitor 62 risedronate sodium tablets 62 QNEXA 62 topical diclofenac 62 Zarnestra 62 oxypurinol 62 ZACTIMA 62 LT NS# 62 MEK inhibitors 62 Glatiramer acetate 62 obatoclax 62 ketoprofen patch 62 edoxaban 62 oral deforolimus 62 Anidulafungin 62 MAP# 62 FROVA 62 lacosamide 62 ularitide 62 wilate ® 62 lisdexamfetamine dimesylate 62 Serdaxin 62 phase Ib 62 ProSavin 62 intracellular uptake 62 M# rationally 62 liposome injection 62 CA4P 62 protease inhibitor PI 62 MICARDIS ® 62 RISPERDAL ® 62 Azilect ® 62 MoxDuo ® 62 XP #L 62 ACTOS ® 62 Pagoclone 62 Phenoptin 62 ritonavir boosted 62 ezogabine 62 Nanobody 62 endothelin antagonists 62 antiepileptic drug 62 treprostinil 62 mycophenolate mofetil 62 risperidone Risperdal 62 orally inhaled 62 Ceflatonin 62 dose regimens 62 R Saizen R 62 delafloxacin 62 balsalazide tablet 62 equi analgesic doses 62 TORISEL 62 TLR agonists 62 ATL# [002] 62 Xelox 62 Trandolapril 62 GAMMAGARD LIQUID 62 ibudilast 62 briakinumab 62 Oracea TM 62 XOPENEX 62 Certican 62 dose proportionality 62 INSPIRE Trial Phase III 62 Fibrin Pad 62 TRIOLEX HE# APOPTONE HE# 62 olanzapine LAI 62 L PPDS 62 Cleviprex TM clevidipine 62 lipid lowering therapies 62 amrubicin 62 EFFEXOR XR 62 Pazopanib 62 sitagliptin Januvia 62 clonidine hydrochloride 62 Heparin Bioactive Surface 62 RSD# oral 62 leukotriene receptor antagonists 62 ataluren 62 rasagiline tablets 62 TNF Tumor Necrosis Factor 62 nonclinical studies 62 CONCERTA 62 intensive lipid lowering 62 Pharmacokinetics PK 62 paclitaxel poliglumex 62 APPRAISE 62 Teriparatide 62 liprotamase 62 pitavastatin 62 esomeprazole Nexium 62 EGFR antibodies 62 CCX# 62 paroxetine Seroxat 62 torsemide ER 62 AstraZeneca Symbicort 62 MACUGEN 62 teduglutide 62 ONGLYZA ™ 62 aspirin clopidogrel 62 somatostatin analogues 62 brand ciclesonide HFA 62 JAK Inhibitor 62 viral kinetics 62 Evoltra ® 62 phase IIa clinical 62 THALOMID 62 platelet inhibition 62 adalimumab Humira 62 motesanib 62 adenosine injection 62 NGX# 62 opioid induced bowel dysfunction 62 oral gallium 61 sertraline Zoloft 61 pharmacologic 61 blinded randomized placebo controlled 61 cardiac toxicity 61 Telavancin 61 Mg Usa 61 boosted protease inhibitor 61 postoperative ileus POI 61 PHX# 61 acyclovir Lauriad R 61 Spiriva HandiHaler 61 Teriflunomide 61 rabeprazole 61 R lenalidomide 61 Sirolimus eluting Coronary Stent 61 aliskiren amlodipine 61 investigational antiplatelet 61 valdecoxib 61 EFAPROXYN 61 hemostatic efficacy 61 clinical endpoints 61 XL# SAR# 61 Topiramate 61 MabThera rituximab 61 SNRI 61 AVERROES 61 TM Drug Eluting 61 candidate TNFerade biologic 61 Benlysta belimumab 61 ACCORD Lipid 61 AzaSite Plus 61 CG# [003] 61 Preclinical studies suggest 61 Pioglitazone 61 investigational hepatitis C 61 imexon 61 ASCEND HF 61 calcineurin inhibitor 61 Panzem NCD 61 TO AVOID PREGNANCY WHILE 61 Cimzia ® 61 Liposomal 61 Advagraf 61 hyperphenylalaninemia HPA due 61 INVEGA SUSTENNA 61 Valdoxan 61 beta 1a 61 clomipramine 61 Synavive ™ 61 thiazolidinedione TZD 61 mecamylamine 61 ATPace TM 61 Sym# 61 acetonide FA 61 sorafenib Nexavar 61 efalizumab 61 tigecycline 61 custirsen 61 omacetaxine mepesuccinate 61 fluticasone salmeterol 61 Candesartan 61 romidepsin 61 Telmisartan 61 LAB CGRP 61 infusional 61 Sanvar R 61 S/GSK# 61 histamine dihydrochloride 61 novel prodrug 61 GW# [003] 61 Vildagliptin 61 Apoptone 61 Aviptadil 61 ROCKET AF 61 APRISO 61 Glypromate 61 hour bronchodilation 61 JAK2 inhibitor 61 Fulvestrant 61 Rasilez Tekturna 61 guanfacine extended release 61 weekly subcutaneous injections 61 TRILIPIX 61 ENMD # 61 cardiac repolarization 61 Glatiramer Acetate 61 Emend 61 Sitagliptin 61 PROMACTA 61 RAPAFLO TM 61 novel histone deacetylase 61 ELIQUIS 61 oxymorphone ER 61 Vascular Wrap 61 Lysteda 61 Xcytrin R 61 Anticalins ® 61 convenient dosing regimen 61 antiplatelet medications 61 SPARLON 61 glatiramer 61 DAVANAT 61 hoFH 61 pharmacodynamic endpoints 61 Phase Ib II 61 Adentri 61 encapsulates siRNAs 61 Durezol 61 INT# [002] 61 PIX# [002] 61 antithrombotic therapy 61 atrasentan 61 mometasone 61 FM VP4 61 tobramycin 61 ponatinib 61 OMNARIS 61 pharmacodynamic profiles 61 CCX# B 61 clobazam 61 vorinostat 61 intravenous formulations 61 anidulafungin 61 efficacy endpoints 61 apremilast 61 Certolizumab pegol 61 pharmacokinetic PK profile 61 Pharmacokinetic 61 davunetide intranasal AL 61 DMARDS 61 Simulect 61 IL# PE#QQR 61 GEM OS2 61 agomelatine 61 Bifeprunox 61 dihydroergotamine 61 Perforomist TM Inhalation Solution 61 posaconazole 61 Duromist ™ 61 atacicept 61 Reclast Aclasta 61 NTx ® -# 61 Ketotransdel TM 61 Losartan 61 aerosolized KL4 surfactant 61 Moxifloxacin 61 GIPET 61 immunomodulatory therapy 61 Kaletra tablets 61 levodopa induced dyskinesia 61 tolerated dose MTD 61 Pruvel 61 Vandetanib 61 ACAPODENE 61 fluticasone furoate 61 systemic hypotension 61 multidose 61 idraparinux 61 Betaferon R 61 calcineurin inhibitors 61 refractory chronic lymphocytic 61 oral transmucosal 61 ELADUR 61 Increlex R 61 echinocandin 61 investigational antiplatelet agent 61 TKM ApoB 61 CRx 61 fidaxomicin 61 prasugrel Effient 61 personalized immunotherapy 61 demonstrated antitumor activity 61 thymalfasin 61 TYKERB 61 DP b# 61 Rasagiline 61 pharmacodynamics 61 Tanespimycin 61 painful diabetic neuropathy 61 Ralivia TM 61 Civacir 61 GLP1 agonist 61 ribavirin USP 61 XOPENEX Inhalation Solution 61 Microplasmin 61 Phase III Clinical Trial 61 Lubiprostone 61 BrachySil 61 induced macular edema 61 coadministration 61 BEXXAR Therapeutic Regimen 61 tadalafil Cialis 61 AVAPRO 61 Lixivaptan 61 JANUVIA 61 MOVIPREP R 61 CIMZIA R 61 oral antiviral 61 Refractory Angina 61 Raptiva R 61 ADP receptor antagonist 61 BeneFIX 61 Medoxomil 61 Neurodex 61 NV1FGF 61 demonstrated clinically meaningful 61 CYT# 61 mTOR inhibition 61 icatibant 61 EGS# 61 gemcitabine Gemzar ® 61 Nebido 61 LEUKINE 61 Non inferiority 61 ispinesib administered 61 cyclophilin inhibitor 61 tasocitinib 61 Dacogen injection 61 everolimus eluting stents 61 CCR5 mAb 61 basal insulin analogue 61 ALVESCO HFA 61 DepoDur TM 61 V Everolimus Eluting Coronary 61 lomitapide 61 dose cohort 61 chronic thromboembolic pulmonary 61 selective estrogen receptor modulator 61 Edarbi 61 Cimzia ® certolizumab pegol 61 Cethrin R 61 TELCYTA 61 Cloretazine R VNP#M 61 Panzem ® 61 Pyridorin 61 Hedgehog inhibitor 61 rufinamide 61 R#/MEM # 61 AstraZeneca Toprol XL 61 secondary efficacy endpoints 61 lipid parameters 61 APTIVUS R 61 rt PA 61 Aflibercept 61 Val HeFT 61 BYETTA exenatide injection 61 pharmacokinetic interactions 61 Interferon alpha 61 Ecallantide 61 RIGScan CR 61 Aggrastat ® tirofiban hydrochloride 61 rilonacept 61 PDX pralatrexate 61 KRAS status 61 sulfonylurea glimepiride 61 injectable formulations 61 BENLYSTA ® 61 antidiabetic drug 61 Bendavia 61 ELACYT 61 antitumor efficacy 61 indiplon capsules 61 Ropinirole 61 Seliciclib 61 brivaracetam 61 Rivaroxaban 61 Huntexil 61 CORDAPTIVE 61 divalproex sodium 61 Itraconazole 61 Vaprisol 61 aleglitazar 61 TAFA# 61 intermittent dosing 61 docetaxel Taxotere 61 PRISTIQ 61 SUSTENNA TM 61 Ciclesonide 61 Frova ® 61 Intervention Effectiveness 61 Captisol enabled 61 ROZEREM TM 61 orBec 61 aldosterone antagonists 61 Phase IIIb clinical 61 HGS ETR2 61 investigational compound 61 lipid lowering agents 61 PRADAXA 61 selective adenosine 61 successfully commercialize Iluvien 61 dacetuzumab 61 paliperidone palmitate 61 eniluracil 61 Bayer Onyx 61 thrombolytic agents 61 bevacizumab Avastin ® 61 somatostatin analog 61 indacaterol 61 RLY# 61 pimecrolimus 61 levocetirizine 61 vascular disrupting agents 61 PDE4 inhibitors 61 Xanafide 61 DPX Survivac 61 Cloretazine 61 Pegloticase 61 levalbuterol 61 subcutaneously administered 61 subcutaneous SC 61 TG# [003] 61 Vaxfectin R 61 factor Xa inhibitor 61 DU #b 61 Ataluren 61 MGd 61 EXALGO 61 RAPAFLO R 61 INTEGRILIN 61 postsurgical pain 61 Aeroquin 61 Degarelix 61 ropinirole Requip 61 propafenone 61 nonrandomized 61 muraglitazar 61 DUROS 61 topical formulations 61 R sorafenib tablets 61 Fluconazole 61 Genz # 61 achieved statistical significance 61 cobiprostone 61 OMNARIS Nasal Spray 61 vascular disrupting agent 61 tipifarnib 61 thorough QT 61 mild vasodilator 61 FASLODEX 61 IMiDs ® 61 Initiates Enrollment 61 vernakalant hydrochloride 61 #:# randomization 61 antiarrhythmic 61 Zemiva TM 61 iniparib 61 Ranolazine 61 escitalopram Lexapro 61 placebo controlled Phase III 61 XIENCE V Everolimus Eluting 60 PDE4 inhibitor 60 quetiapine Seroquel 60 Interferon beta 1b 60 Entereg TM 60 anticancer activity 60 MEND CABG II 60 CYCLOSET 60 tizanidine hydrochloride short 60 antithrombotic agents 60 oral methylnaltrexone 60 rheumatoid arthritis osteoarthritis ankylosing 60 induce remission 60 BoNTA 60 ospemifene 60 Tiotropium 60 sulodexide 60 newer atypical antipsychotics 60 Mitoxantrone 60 RezularTM 60 GLPG# 60 nucleoside analog 60 antiarrhythmic agent 60 epoprostenol 60 Valtropin 60 Pegasys ®